Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

Abbott acquisition of Alere set to close on October 3, 2017

Press releases may be edited for formatting or style | October 02, 2017 Cardiology
WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR) announced today that Abbott's acquisition of Alere is intended to close on October 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing.

Alere intends to request that the New York Stock Exchange cease trading of Alere's common stock before market open on October 3, 2017.

About Alere

Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology.

SOURCE Alere Inc.

You Must Be Logged In To Post A Comment